Induction of Erythroid Differentiation of Human Leukemia K562 Cells by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) — Sigrid Hatse (1995) | RDL Network
Abstract 9-(2-Phosphonylmethoxyethyl)adenine (PMEA), the prototype compound of a well-defined structural class of potent and selective anti-retroviral agents, was found to be endowed with long-lasting and dose-dependent differentiation-inducing properties in human erythroleukemia K562 cell cultures.
Katrin Hartmann, M Kuffer, Jan Balzarini, Lieve Naesens, Michel Goldberg, Volker Erfle, Frank-Detlef Goebel, De Clercq Erik, Jindřich Jindřich, Antonı́n Holý, Norbert Bischofberger, W Kraft
Discussion(0)
No comments yet. Be the first to comment.